MONJUVI (tafasitamab-cxix) for injection

To get best price/cost of Raxone (idebenone) tablets in India, Call 9811747774 or Email info@medvitaz.com to discuss. To treat odiffuse large B-cell lymphoma (DLBCL).
Categories: , .

MONJUVI (tafasitamab-cxix) for injection. FDA-Approved. To treat lymphoma

What is FDA-approved MONJUVI (tafasitamab-cxix) for injection indicated for?

MONJUVI (tafasitamab-cxix) for injection is a prescription medicine. MONJUVI (tafasitamab-cxix) for injection is used to treat odiffuse large B-cell lymphoma (DLBCL).
INDICATIONS AND USAGE
MONJUVI is a CD19-directed cytolytic antibody indicated in combination with lenalidomide for the treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL) not otherwise specified,
including DLBCL arising from low grade lymphoma, and who are not eligible for autologous stem cell transplant (ASCT).
This indication is approved under accelerated approval based on overall response rate. Continued approval for this indication may be contingent upon verification and description of clinical benefit in a confirmatory trial(s).
DOSAGE FORMS & STRENGTHS
For injection: 200 mg of tafasitamab-cxix as lyophilized powder in singledose vial for reconstitution.
Manufactured By: MORPHOSYS US INC
Prescribing Information URL: Click Here

How to make an enquiry for MONJUVI (tafasitamab-cxix) for injection?

Anticancer medicine MONJUVI (tafasitamab-cxix) for injection available upon request. To get best price in india, Call 9811747774 or Email info@medvitaz.com to discuss advanced treatments with Blood Cancer Specialists in India without travel. Medvitaz Pharma Solutions can help you to get genuine, affordable and assurance of delivery of approved medicines for Blood Cancer.

What Tafasitamab is indicated for?

Tafasitamab, sold under the brand name Monjuvi, is a medication used in combination with lenalidomide for the treatment of adults with relapsed or refractory diffuse large B-cell lymphoma (DLBCL).

Tafasitamab may cause serious side effects including infusion related reactions, bone marrow suppression, infections, and harm to an unborn baby. The most common side effects of tafasitamab are low blood cell counts, fatigue, diarrhea, cough, fever, limb swelling, upper respiratory infection, and decreased appetite.

Tafasitamab is a humanized Fc-modified cytolytic CD19 antibody.

Tafasitamab was approved for medical use in the United States in July 2020. The U.S. Food and Drug Administration (FDA) considers it to be a first-in-class medication.

How and where to buy MONJUVI (tafasitamab-cxix) for injection?

You can order MONJUVI (tafasitamab-cxix) for injection from Medvitaz Pharma Solutions if the drug has not been approved or is not available in your country. We help you to get genuine, affordable and assurance of delivery of approved medicines for Blood Cancer. To get best price/cost of MONJUVI (tafasitamab-cxix) for injection in India, Call 8750295029 or Email urgent@medvitaz.com. FDA approved drugs of Australia, Canada, Delhi, EU, India, New Zealand, Singapore, Switzerland, Turkey & USA.

neeraj
Neeraj Nagpal

Head of Operations

 The profound knowledge of more than 20 years in sales and marketing sector, he has been working dedicatedly and contributing to pharmaceuticals industry. He handles all operations over the country.

Contact Our Team

Contact us and we will reply as soon as possible!

    need help?

     MEDVITAZ is an initiative for helping end-users directly to get the right medicines and right medical treatments from the right source.